NA
NVO

Navellier & Associates’s Novo Nordisk NVO Stock Holding History

Navellier & Associates’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-5,082
Closed -$437K – 361
2024
Q4 		$437K Sell
5,082
-113,383
-96% -$12.3M 0.05% 248
2024
Q3 		$14.1M Sell
118,465
-7,346
-6% -$980K 1.91% 7
2024
Q2 		$18M Buy
125,811
+11,980
+11% +$1.59M 2.11% 7
2024
Q1 		$14.6M Buy
113,831
+1,484
+1% +$177K 1.8% 8
2023
Q4 		$11.6M Buy
112,347
+7,236
+7% +$716K 1.74% 8
2023
Q3 		$9.56M Sell
105,111
-193
-0.2% -$17K 1.64% 9
2023
Q2 		$8.52M Buy
105,304
+44,590
+73% +$3.64M 1.66% 6
2023
Q1 		$4.83M Buy
+60,714
New +$4.31M 1.02% 18
2015
Q4 		– Sell
-31,484
Closed -$854K – 282
2015
Q3 		$854K Sell
31,484
-20,738
-40% -$587K 0.09% 100
2015
Q2 		$1.43M Buy
52,222
+17,572
+51% +$494K 0.13% 92
2015
Q1 		$925K Sell
34,650
-1,226
-3% -$28.2K 0.08% 121
2014
Q4 		$759K Sell
35,876
-168
-0.5% -$3.75K 0.04% 137
2014
Q3 		$858K Buy
36,044
+12,586
+54% +$290K 0.04% 117
2014
Q2 		$542K Sell
23,458
-1,288
-5% -$28.4K 0.02% 180
2014
Q1 		$565K Sell
24,746
-204
-0.8% -$4.35K 0.03% 155
2013
Q4 		$461K Buy
24,950
+4,260
+21% +$74.2K 0.02% 190
2013
Q3 		$350K Sell
20,690
-5,410
-21% -$91K 0.01% 223
2013
Q2 		$404K Buy
+26,100
New +$434K 0.02% 161

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
TIM
Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return

Navellier & Associates's NVO Position: Q1 2025 in Review

Navellier & Associates sold out of Novo Nordisk (NVO) in Q1 2025, closing a stake of 5,082 shares — an estimated $437K sold.

Navellier & Associates first reported a position in NVO in Q2 2013 and held it in 18 quarters. The position peaked at $18M in Q2 2024. 1,529 funds tracked by Wall St. Rank hold NVO as of Q1 2025.

  • Navellier & Associates reported no remaining Novo Nordisk position as of Q1 2025 after selling out during the quarter.
  • Navellier & Associates sold 5,082 Novo Nordisk shares in Q1 2025, an estimated $437K.
  • Navellier & Associates first reported a position in Novo Nordisk in Q2 2013 and held it in 18 quarters.
  • Navellier & Associates's Novo Nordisk position peaked at $18M in Q2 2024.
  • 1,529 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2025.

Based on Navellier & Associates's 13F filing for Q1 2025, filed 6 May 2025.